CHAF1B
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
171665single nucleotide variantNM_005441.2(CHAF1B):c.862A>G (p.Thr288Ala)193921141MedGen:C0376358,OMIM:176807,SNOMED CT:C0376358213640940836409408AG
171665single nucleotide variantNM_005441.2(CHAF1B):c.862A>G (p.Thr288Ala)193921141MedGen:C0376358,OMIM:176807,SNOMED CT:C0376358213778170637781706AG
181465single nucleotide variantNM_005441.2(CHAF1B):c.496A>G (p.Ile166Val)140630794Human Phenotype Ontology:HP:0007018,MedGen:CN006126;Human Phenotype Ontology:HP:0001263,MedGen:CN001157;Human Phenotype Ontology:HP:0001249,MedGen:C3714756213639742936397429AG
181465single nucleotide variantNM_005441.2(CHAF1B):c.496A>G (p.Ile166Val)140630794Human Phenotype Ontology:HP:0007018,MedGen:CN006126;Human Phenotype Ontology:HP:0001263,MedGen:CN001157;Human Phenotype Ontology:HP:0001249,MedGen:C3714756213776972737769727AG
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1028347988rs2252206AGrs22522060.000795METHIONINECASPASE 1|CASPASE 9|CASP9 PROTEIN, HUMAN|5'-METHYLTHIOADENOSINE|APIP PROTEIN, HUMAN|DEOXYADENOSINES|THIONUCLEOSIDES|APOPTOSIS REGULATORY PROTEINSSalmonella-induced pyroptosisNANAGintronGWASdb_drug
1028353751rs7909706TCrs79097066.30E-05CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409TintronGWASdb_drug
1028391617rs4749306CGrs47493061.49E-04CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_drug
1028393824rs10826398GTrs108263981.67E-05CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_drug
1028424177rs4317882GArs43178827.51E-05CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_drug
1028432044rs4506531CGrs45065317.51E-05CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_drug
1028450599rs2985523TGrs29855233.16E-04CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409AintronGWASdb_drug
1028470732rs11006913AGrs110069136.39E-05CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409AintronGWASdb_drug
1028475495rs2985535CTrs29855352.75E-04CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_drug
1028476148rs1937809CTrs19378092.75E-04CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409TintronGWASdb_drug
1028489647rs7922685CGrs79226851.02E-04CISPLATIN|ETOPOSIDE|CARBOPLATINR-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINSResponse to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_drug
1028541472rs1870097TCrs18700978.31E-04ATORVASTATINSERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASESResponse to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287AintronGWASdb_drug
1028346035rs7920857GCrs79208573.27E-04Insulin resistanceHPOID:0000855DOID:9352GintronGWASdb_trait
1028347988rs2252206AGrs22522060.000795Salmonella-induced pyroptosisNANAGintronGWASdb_trait
1028353751rs7909706TCrs79097066.30E-05Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409TintronGWASdb_trait
1028373644rs4749301TCrs47493015.80E-04Alcohol dependenceHPOID:0000707DOID:0050741TintronGWASdb_trait
1028382933rs927675ACrs9276752.00E-06MRI atrophy measuresHPOID:0001626DOID:10652TintronGWASdb_trait
1028388150rs10763642GArs107636427.00E-06Obesity-related traitsHPOID:0001513DOID:9970GintronGWASdb_trait
1028391617rs4749306CGrs47493061.49E-04Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_trait
1028393824rs10826398GTrs108263989.81E-05Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
1028393824rs10826398GTrs108263981.67E-05Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_trait
1028400835rs12776665CArs127766652.57E-06Total ventricular volumeHPOID:0001627DOID:10652CintronGWASdb_trait
1028415164rs2490062ATrs24900620.0000612Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37TintronGWASdb_trait
1028424177rs4317882GArs43178827.51E-05Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_trait
1028432044rs4506531CGrs45065319.96E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
1028432044rs4506531CGrs45065317.51E-05Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_trait
1028438930rs147999424GArs1479994240.000038Breast cancer (ER positive)HPOID:0003002DOID:1612GmissenseGWASdb_trait
1028442841rs9299597GArs92995970.000634026Hypertension (early onset hypertension)HPOID:0000822DOID:10763GintronGWASdb_trait
1028446745rs2985532TCrs29855320.0000556Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37TintronGWASdb_trait
1028449974rs7081378GArs70813788.74E-04Alzheimer's diseaseHPOID:0002511DOID:10652GintronGWASdb_trait
1028450599rs2985523TGrs29855233.16E-04Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409AintronGWASdb_trait
1028450599rs2985523TGrs29855230.0000632Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37AintronGWASdb_trait
1028451249rs12254584CArs122545844.04E-04Alzheimer's diseaseHPOID:0002511DOID:10652CintronGWASdb_trait
1028451289rs2985522TCrs29855220.0000343Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37AintronGWASdb_trait
1028451524rs1626856TArs16268560.0000665Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37AintronGWASdb_trait
1028452867rs1781832TCrs17818320.0000677Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37CintronGWASdb_trait
1028453046rs2763316AGrs27633160.0000684Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37AintronGWASdb_trait
1028453145rs1781833GCrs17818330.0000685Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37GintronGWASdb_trait
1028453225rs1781834TCrs17818340.0000684Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37CintronGWASdb_trait
1028453354rs1781835TCrs17818350.0000684Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37TintronGWASdb_trait
1028453677rs1748484TArs17484840.000074Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37TintronGWASdb_trait
1028453966rs2801843AC,G,Trs28018430.0000895Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37CintronGWASdb_trait
1028453981rs2801844GTrs28018440.0000688Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37TintronGWASdb_trait
1028454152rs2801845ATrs28018458.20E-04Multiple complex diseasesHPOID:0000118NATintronGWASdb_trait
1028454533rs7085245TGrs70852453.52E-04Alzheimer's diseaseHPOID:0002511DOID:10652TintronGWASdb_trait
1028454570rs7101051CArs71010519.33E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
1028455529rs2985517TCrs29855170.0000673Nonsyndromic striae distensae (stretch marks)HPOID:0001000DOID:37AintronGWASdb_trait
1028462933rs2887214TArs28872143.55E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
1028466013rs7914949TCrs79149492.00E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
1028466881rs35494924TCrs354949242.68E-06Bone mineral densityHPOID:0004348DOID:0080011TintronGWASdb_trait
1028470732rs11006913AGrs110069136.39E-05Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409AintronGWASdb_trait
1028475495rs2985535CTrs29855352.75E-04Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409GintronGWASdb_trait
1028476148rs1937809CTrs19378093.36E-04Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
1028476148rs1937809CTrs19378092.75E-04Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409TintronGWASdb_trait
1028479942rs3905706CTrs39057062.00E-16Bone mineral densityHPOID:0004348DOID:0080011GintronGWASdb_trait
1028479942rs3905706CTrs39057068.00E-06Bone mineral densityHPOID:0004348DOID:0080011GintronGWASdb_trait
1028479942rs3905706CTrs39057062.93E-06Bone mineral density (paediatric, skull)HPOID:0004348DOID:0080011GintronGWASdb_trait
1028479942rs3905706CTrs39057063.00E-06Bone mineral density (paediatric, skull)HPOID:0004348DOID:0080011GintronGWASdb_trait
1028489647rs7922685CGrs79226851.02E-04Response to platinum-based chemotherapy in small-cell lung cancerHPOID:0100526DOID:5409CintronGWASdb_trait
1028504944rs11006923TCrs110069239.00E-06Alzheimer's diseaseHPOID:0002511DOID:10652TintronGWASdb_trait
1028514249rs11006928ATrs110069281.04E-05Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
1028515799rs17831816GArs178318169.19E-06Alzheimer's diseaseHPOID:0002511DOID:10652GintronGWASdb_trait
1028540477rs11006950CGrs110069501.02E-04Alzheimer's diseaseHPOID:0002511DOID:10652CintronGWASdb_trait
1028541472rs1870097TCrs18700978.31E-04Response to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287AintronGWASdb_trait
1028544070rs11006958ACrs110069581.32E-05Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
1028560451rs7086943TCrs70869436.14E-04Insulin resistanceHPOID:0000855DOID:9352TintronGWASdb_trait
1028567807rs7905490CTrs79054903.22E-04Acute lung injuryHPOID:0002088DOID:850TintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000159259.7 CHAF1B 601245